SCHEMBL5584746

SCHEMBL5584746

Cc1cc(-c2cc3cccc(O)c3o2)on1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2RL3 Q96RI0 1/20 0.43
ALDH1A1 P00352 2/20 0.41
MAOA P21397 5/20 0.41
MAOB P27338 4/20 0.41
PDE4D Q08499 1/20 0.40
KDM4E B2RXH2 1/20 0.40
USP2 O75604 1/20 0.40
TSHR P16473 1/20 0.40
LCK P06239 1/20 0.40
AKR1C3 P42330 2/20 0.39
AR P10275 1/20 0.39
CBR1 P16152 1/20 0.39
DNM2 P50570 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5584420 0.81 ALDH1A1 (0.53) F2RL3ALDH1A1KDM4EADORA2AADORA1
SCHEMBL5584930 0.77 F2RL3 (0.44) F2RL3ALDH1A1MAOAPDE4DKDM4E
SCHEMBL5585039 0.77 L3MBTL1 (0.50) F2RL3MAOAMAOBPDE4DLCK
SCHEMBL5584613 0.72 MAOA (0.42) F2RL3MAOAMAOBPDE4DLCK
SCHEMBL5649730 0.71 RAB9A (0.66) ALDH1A1KDM4EUSP2TSHR
SCHEMBL5584224 0.71 PDE4D (0.42) F2RL3MAOAMAOBPDE4DKDM4E
SCHEMBL5003621 0.70 MAOA (0.59) MAOAMAOBKDM4ELCKAKR1C3
SCHEMBL30892693 0.69 MAOA (0.66) ALDH1A1MAOAMAOBKDM4EAKR1C3
SCHEMBL8291485 0.69 CYP1A1 (0.49) MAOAMAOBPDE4DKDM4ELCK
SCHEMBL14231755 0.68 MAOB (0.75) F2RL3ALDH1A1MAOAMAOBADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7196199-B2 Antiserotonine agents; antidepressants MITSUBISHI PHARMA CORPORATION (JP) 2007-03-27 US disclosed
EP-1188747-B1 PHENOXYPROPYLAMINE COMPOUNDS MITSUBISHI PHARMA CORP (JP) 2005-09-07 EP disclosed
US-20040138227-A1 Phenoxypropylamine compounds NISHIYAMA AKIRA 2004-07-15 US disclosed
EP-1188747-A1 PHENOXYPROPYLAMINE COMPOUNDS Mitsubishi Pharma Corporation (JP) 2002-03-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138227-A1 Phenoxypropylamine compounds HTR1A, HTR1D, HTR5A F2RL3 3870/4885ALDH1A1 443/4885MAOA 75/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.